Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

The reduction of hypoglycemia among inpatients through a multidisciplinary team work using a PDCA approach

Authors: Thalita Barreira Modena Cardim, Magda Tiemi Yamamoto, Adriana de Fátima Avansi, Gustavo Daher, Rodrigo Bomeny de Paulo, Claudia Regina Laselva, Rogério Silicani Ribeiro, Jose Antonio Maluf de Carvalho

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Hypoglycemia is associated with transient cognitive deficits and can result in cardiac arrhythmia, neurological damage, falls or aspiration. Among critical and non-critical inpatients, hypoglycemia increases the risk of death. Since 2012, we had kept the rate of hypoglycemia (proportion of capillary glucose episodes bellow 60 mg/dL per 100 glucose measurements) well controlled. During the first 3 months of 2014 we were aiming to keep the rate under 0,46%. However, there was an average of 149 episodes/month, which was equivalent to the rate of 0,57%. …
Metadata
Title
The reduction of hypoglycemia among inpatients through a multidisciplinary team work using a PDCA approach
Authors
Thalita Barreira Modena Cardim
Magda Tiemi Yamamoto
Adriana de Fátima Avansi
Gustavo Daher
Rodrigo Bomeny de Paulo
Claudia Regina Laselva
Rogério Silicani Ribeiro
Jose Antonio Maluf de Carvalho
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A48

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue

Meeting abstract

Homologies between Bauhinia forficata Link subsp. pruinosa and pancreatic beta-cell specific transcriptional activator: a starting point for drug design new in diabetes?

Meeting abstract

Insulin topical modulates inflammatory phase and the angiogenesis of the burns wound healing in diabetic-induced rats

Meeting abstract

Experimental model of type 2 diabetes induced by fat diet consumption and low dose of streptozotocin in C57BL/6J mice

Meeting abstract

Main barriers on glucometer utilization during physician's appointment of insulin users T2D patients

Meeting abstract

Perceptions of primary care professionals about sharing patient care with endocrinologist medium sized-city

Meeting abstract

Hypertriglyceridemic waist phenotype indicates insulin resistance in adolescents: validation study front hyperglycemic clamp-Brazilian Metabolic Syndrome Study (BRAMS)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits